In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Carolyn Sp Lam
Speaker
Carolyn Sp Lam
Carolyn Sp Lam Carolyn Sp Lam

National Heart Centre Singapore, Singapore (Singapore)

Specialities : Chronic Heart Failure , e-Cardiology, Other

63 presentations from this speaker

Based on what we know today, what should be the foundational therapy for heart failure patients? Summary and Conclusion.

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG)
  • Sponsorered by Novartis Pharma AG

Experts on the Spot: Cardiac remodelling and outcomes.

Event : HFA Discoveries 2020

  • Session : Experts on the Spot: Cardiac remodelling and outcomes
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsored by Novartis Pharma AG

Introduction

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS)
  • Sponsorered by Novartis Pharma AG

Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsorered by Novartis Pharma AG

SGLT2 inhibition: Making waves in the heart failure landscape.

Event : HFA Discoveries 2020

  • Session : SGLT2 inhibition: Making waves in the heart failure landscape
  • Speaker : CS Lam (Singapore,SG), J Butler (Atlanta,US), M Petrie (Glasgow,GB), GMC Rosano (London,GB)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre

ASIAN HF and ATTRACT studies: the strength of an Asian collaboration.

Event : ESC Congress 2019

  • Session : Why should registry data impact clinical practice?
  • Speaker : CS Lam (Singapore,SG)
  • Joint with the Asian Pacific Society of Cardiology

ASIAN-HF and ATTRACT: a purpose built Asian Registry for Chronic Heart Failure.

Event : ESC Asia 2019

  • Session : Regional Registries and Trials
  • Speaker : CS Lam (Singapore,SG)

Cardiovascular disease in Asia: what place for women?

Event : ESC Congress 2019

  • Session : Cardiovascular disease and women: global threat or macro-opportunity
  • Speaker : CS Lam (Singapore,SG)
  • Promoted by Women in ESC

Case 3: the patient with HFpEF and atrial fibrillation

Event : ESC Congress 2019

  • Session : Meet the Experts - Heart failure drug therapy in patients with co-morbidities
  • Speaker : CS Lam (Singapore,SG)

Clinical phenotype of HFpEF: the same around the world?

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : CS Lam (Singapore,SG)

Conclusion

Event : ESC Congress 2019

  • Session : The heart failure challenge: how well do you know HFpEF?
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Conclusion and final comments

Event : Heart Failure 2019

  • Session : Meet the experts on getting to grips with HFpEF
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Data from clinical trials.

Event : Heart Failure 2019

  • Session : HFmEF: clinical and therapeutic dilemmas
  • Speaker : CS Lam (Singapore,SG)

Discussions, questions and answers

Event : ESC Congress 2019

  • Session : Treating patients with HFpEF: what progress are we making?
  • Speaker : CS Lam (Singapore,SG), JJV McMurray (Glasgow,GB), S Solomon (Boston,US)
  • Sponsored by Novartis Pharma AG

Epidemiology of heart failure: incidence, prevalence, and risk factors from a systematic review

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : CS Lam (Singapore,SG)

Experts debate - Challenges faced in diagnosing and managing HFpEF.

Event : Heart Failure 2019

  • Session : Challenges faced in diagnosing and managing HFpEF
  • Speaker : CS Lam (Singapore,SG), JJV McMurray (Glasgow,GB), B Pieske (Berlin,DE), L Lund (Stockholm,SE), A Voors (Groningen,NL)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Future Direction for Heart Failure with Preserved Ejection Fraction

Event : ESC Asia 2019

  • Session : All I Should Know about Heart Failure with Preserved Ejection Fraction
  • Speaker : CS Lam (Singapore,SG)

Heart failure and cardiomyopathies.

Event : ESC Congress 2019

  • Session : ESC Congress Highlights
  • Speaker : CS Lam (Singapore,SG)

HFpEF past, present and future

Event : Heart Failure 2019

  • Session : Meet the experts on getting to grips with HFpEF
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an educational grant from Novartis

How well do you know HFpEF? - Questions and panel discussion

Event : ESC Congress 2019

  • Session : The heart failure challenge: how well do you know HFpEF?
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Imaging.

Event : Heart Failure 2019

  • Session : The year's best papers on heart failure
  • Speaker : CS Lam (Singapore,SG)

Joining the pieces: the heart-kidney connection.

Event : Heart Failure 2019

  • Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Bayer AG

Key learnings and close

Event : ESC Congress 2019

  • Session : Treating patients with HFpEF: what progress are we making?
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Novartis Pharma AG

Panel discussion

Event : Heart Failure 2019

  • Session : Meet the experts on getting to grips with HFpEF
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Q&A and closing - Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together.

Event : Heart Failure 2019

  • Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
  • Speaker : M Cowie (London,GB), K Branch (Seattle,US), H Bonnemeier (Kiel,DE), CS Lam (Singapore,SG)
  • Sponsored by Bayer AG

Quiz: what do you know about HFpEF?

Event : ESC Congress 2019

  • Session : The heart failure challenge: how well do you know HFpEF?
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Real world practices and outcomes in the management of heart failure patients with T2DM.

Event : Heart Failure 2019

  • Session : Heart Failure, diabetes & SGLT2 inhibition: time to change practice?
  • Speaker : CS Lam (Singapore,SG)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim

Welcome and introduction

Event : ESC Congress 2019

  • Session : Treating patients with HFpEF: what progress are we making?
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Novartis Pharma AG

Welcome and introduction

Event : ESC Congress 2019

  • Session : The heart failure challenge: how well do you know HFpEF?
  • Speaker : CS Lam (Singapore,SG)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Case 1 - Is HFpEF real?

Event : ESC Congress 2018

  • Session : Therapeutic dilemmas in heart failure : debate of the experts
  • Speaker : M Jessup (Hingham,US), CS Lam (Singapore,SG), S Solomon (Boston,US)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Case 2: My HF patient post-hospitalization is easy to manage!

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : CS Lam (Singapore,SG), J Cleland (Glasgow,GB)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Diagnosing HFpEF during atrial fibrillation

Event : Heart Failure 2018

  • Session : Atrial fibrillation and HFpEF - Just twins?
  • Speaker : CS Lam (Singapore,SG)

Dilemmas in heart failure management: what do the experts say?

Event : ESC Congress 2018

  • Session : Dilemmas in heart failure management: what do the experts say?
  • Speaker : CS Lam (Singapore,SG), B Pieske (Berlin,DE), S Solomon (Boston,US), F Ruschitzka (Zurich,CH), M Jessup (Hingham,US)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Examining heart failure cases with the experts: challenges faced.

Event : Heart Failure 2018

  • Session : Examining heart failure cases with the experts: challenges faced
  • Speaker : CS Lam (Singapore,SG), M Packer (Dallas,US), J Cleland (Glasgow,GB)
  • Sponsored by Novartis

HFpEF: from understanding the physiology to development of new treatments.

Event : Heart Failure 2018

  • Session : Novel concepts and treatments of comorbidities in heart failure with preserved ejection fraction
  • Speaker : CS Lam (Singapore,SG)
  • Organised by PACE and UMCG, supported with educational grants by Novartis and Novo Nordisk

Iron deficiency: an important comorbidity - Discussion and questions.

Event : Heart Failure 2018

  • Session : Iron deficiency: an important comorbidity
  • Speaker : S Anker (Berlin,DE), P Van Der Meer (Groningen,NL), CS Lam (Singapore,SG), EA Jankowska (Wroclaw,PL)
  • Sponsored by Vifor Pharma

Managing iron deficiency: a practical approach.

Event : Heart Failure 2018

  • Session : Iron deficiency: an important comorbidity
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Medical therapy

Event : Heart Failure 2018

  • Session : HFpEF - The new HFA consensus
  • Speaker : CS Lam (Singapore,SG)

New diagnostic algorithms in HFpEF

Event : ESC Congress 2018

  • Session : Expert Advice - Diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF)
  • Speaker : CS Lam (Singapore,SG)

Role of biomarkers in CVD intensive preventive therapy among T2DM - current guidelines and future perspectives.

Event : Heart Failure 2018

  • Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Roche

Will this change my clinical practice?

Event : Heart Failure 2018

  • Session : Interpretation of biomarkers in chronic heart failure – Easier said than done
  • Speaker : CS Lam (Singapore,SG)

Your questions on dilemmas in the treatment of heart failure answered.

Event : Heart Failure 2018

  • Session : Your questions on dilemmas in the treatment of heart failure answered
  • Speaker : JJV McMurray (Glasgow,GB), CS Lam (Singapore,SG)
  • Sponsored by Novartis

Burden and impact of iron deficiency in heart failure.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Conclusion and take-home messages

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : CS Lam (Singapore,SG)

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium levels.

Event : Heart Failure 2017

  • Session : Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels
  • Speaker : M Boehm (Homburg,DE), CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma/Vifor Fresenius Medical Care Renal Pharma

Heart failure with mid-range ejection fraction - Conclusion and take home message.

Event : ESC Congress 2017

  • Session : Heart failure with mid-range ejection fraction - What does it mean for clinical practice?
  • Speaker : CS Lam (Singapore,SG)

Should iron be at the heart of concerns?

Event : ESC Congress 2017

  • Session : Hyperkalaemia and iron deficiency: how too much or too little may affect the heart
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Treatment.

Event : Heart Failure 2017

  • Session : A practical guide: how to manage heart failure with mid-range ejection fraction (HFmrEF)?
  • Speaker : CS Lam (Singapore,SG)

Are patients missing out? Will new therapy options lead to better heart failure management?

Event : Heart Failure 2016

  • Session : Hyperkalaemia: are your patients missing out?
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Ethnic and regional variation in diabetes among Asian patients with heart failure

Event : ESC Congress 2016

  • Session : Fighting againts diabetes epidemic
  • Speaker : CS Lam (Singapore,SG)

Macrovascular endothelial dysfunction.

Event : ESC Congress 2016

  • Session : Heart failure with preserved ejection fraction
  • Speaker : CS Lam (Singapore,SG)

Panel discussion.

Event : Heart Failure 2016

  • Session : Iron deficiency in heart failure. Guidelines: implementation in clinical practice
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Welcome and introduction.

Event : Heart Failure 2016

  • Session : Hyperkalaemia: are your patients missing out?
  • Speaker : CS Lam (Singapore,SG), B Pitt (Ann Arbor,US)
  • Sponsored by Vifor Pharma

Harnessing cyclic GMP signaling for cardiovascular protection - Take home message.

Event : ESC Congress 2015

  • Session : Harnessing cyclic GMP signalling for cardiovascular protection
  • Speaker : CS Lam (Singapore,SG)

Implication and perspectives.

Event : ESC Congress 2015

  • Session : Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by ResMed

Panel discussion – Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond.

Event : ESC Congress 2015

  • Session : Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond
  • Speaker : M Cowie (London,GB), K Wegscheider (Hamburg,DE), H Woehrle (Ulm,DE), CS Lam (Singapore,SG), F Ruschitzka (Zurich,CH), M Metra (Brescia,IT)
  • Sponsored by ResMed

Pulmonary hypertension.

Event : Heart Failure 2015

  • Session : Heart failure with preserved ejection fraction: what´s the key mechanism?
  • Speaker : CS Lam (Singapore,SG)

The unique risk intersection of heart failure and diabetes: lessons learned from real world evidence.

Event : Heart Failure 2015

  • Session : What's hot in heart failure: defining unmet medical needs and innovative targets for therapy
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Bayer Healthcare

Does it exist?

Event : ESC Congress 2014

  • Session : Challenges in heart failure with preserved ejection fraction
  • Speaker : CS Lam (Singapore,SG)

Iron deficiency: a common neglected burden in HF.

Event : ESC Congress 2014

  • Session : Iron deficiency in heart failure – The relevance for the patient
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

What should cardiologists know about sleep disordered breathing & heart failure in 2014?

Event : ESC Congress 2014

  • Session : Sleep disordered breathing in heart failure; time for cardiologists to take control
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by ResMed

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are